Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (1264) Longitudinal and Cohort Studies in Public Health (944) Descriptive Epidemiology and Population Size Estimates (237) Secondary Use of Clinical Data for Research and Surveillance (649) Gastroenterology and Hepatology (207) Research Infrastructures and Registries (105)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/89577, first published .
Doctor analyzes liver health data on France map with charts and laptop

RESONANCE: Protocol for a Nationwide Cohort Study of Chronic Liver Diseases Using the French National Health Data System

RESONANCE: Protocol for a Nationwide Cohort Study of Chronic Liver Diseases Using the French National Health Data System

Authors of this article:

Aurore Baron1, 2 Author Orcid Image ;   Laure Tron1, 3 Author Orcid Image ;   Frédéric Balusson4, 5 Author Orcid Image ;   Vaele Zannou1 Author Orcid Image ;   Victoria Mignot1 Author Orcid Image ;   Anne Ego6, 7 Author Orcid Image ;   Anna Borowick3 Author Orcid Image ;   Thomas Decaens3 Author Orcid Image ;   Emmanuel Oger4, 5 Author Orcid Image ;   Sébastien Bailly8 Author Orcid Image ;   Charlotte Costentin1, 3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Aurore Baron   1, 2 * , MD, MSc ;   Laure Tron   1, 3 * , PhD ;   Frédéric Balusson   4, 5 , PhD ;   Vaele Zannou   1 , MSc ;   Victoria Mignot   1 , MD, MSc ;   Anne Ego   6, 7 , MD, PhD ;   Anna Borowick   3 , PhD ;   Thomas Decaens   3 , Prof Dr Med ;   Emmanuel Oger   4, 5 , Prof Dr Med ;   Sébastien Bailly   8 , PhD ;   Charlotte Costentin   1, 3 , Prof Dr Med

1 Université Grenoble Alpes, Institute for Advanced Biosciences, Research Center UGA Inserm U 1209 - CNRS UMR 5309, Team Cell Dynamics, Metabolism & Cancer (DIMAC), Grenoble, Île-de-France, France

2 Université Paris Saclay, Centre Hépato-Biliaire, Hôpital Paul-Brousse, Inserm UMR 1193, Villejuif, France

3 Université Grenoble Alpes, Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes, La Tronche, Grenoble, France

4 Pharmacovigilance and Pharmacoepidemiology, CHU Rennes, Rennes, France

5 Université Rennes, CHU Rennes, Inserm, EHESP, Irset, UMR_S 1085, Rennes, France

6 Université Grenoble Alpes, Pôle Santé Publique, Centre Hospitalier Universitaire de Grenoble, Grenoble, France

7 Université Grenoble Alpes, TIMC-IMAG, UMR 5525, CNRS, Equipe ThEMAS, Grenoble, France

8 Université Grenoble Alpes, HP2 Laboratory, Inserm U1300, Grenoble, France

*these authors contributed equally

Corresponding Author:

  • Charlotte Costentin, Prof Dr Med
  • Université Grenoble Alpes
  • Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes
  • Avenue Maquis du Grésivaudan
  • La Tronche, Grenoble 38700
  • France
  • Phone: 33 4-76-76-75-75
  • Fax: 33 4-76-76-51-79
  • Email: CCostentin@chu-grenoble.fr